Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A Vos

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
European Journal of Epidemiology|June 11, 2021
Estimating the asymptomatic proportion of SARS-CoV-2 infection in the general population: Analysis of nationwide serosurvey data in the NetherlandsScott A McDonald, Fuminari Miura, Eric R A Vos, et al.
Vaccine|November 29, 2021
Seroprevalence of meningococcal ACWY antibodies across the population in the Netherlands: Two consecutive surveys in 2016/17 and 2020Milou Ohm, Mirjam J Knol, Eric R A Vos, et al.
Nature Communications|February 20, 2026
Antibody waning and Bordetella pertussis resurgence after the COVID-19 pandemic in the NetherlandsChannah M Gaasbeek, Eric R A Vos, Annika M van Roon, et al.
Scientific Reports|March 30, 2023
Dynamics of non-household contacts during the COVID-19 pandemic in 2020 and 2021 in the NetherlandsJantien A Backer, Laurens Bogaardt, Philippe Beutels, et al.
Plos One|March 18, 2024
Health-related quality of life during the COVID-19 pandemic: The impact of restrictive measures using data from two Dutch population-based cohort studiesCheyenne C E van Hagen, Anne J Huiberts, Elizabeth N Mutubuki, et al.
Influenza and Other Respiratory Viruses|June 5, 2024
SARS-CoV-2 Seroprevalence Trends in the Netherlands in the Variant of Concern Era: Input for Future ResponseEric R A Vos, Cheyenne C E van Hagen, Denise Wong, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 27, 2021
Associations Between Measures of Social Distancing and Severe Acute Respiratory Syndrome Coronavirus 2 Seropositivity: A Nationwide Population-based Study in the NetherlandsEric R A Vos, Michiel van Boven, Gerco den Hartog, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|August 18, 2021
Circulation of Bordetella pertussis in the Caribbean Netherlands: a population-based seroepidemiological studyMaarten M Immink, Eric R A Vos, Alcira V A Janga-Jansen, et al.
Journal of Epidemiology and Community Health|November 29, 2020
Nationwide seroprevalence of SARS-CoV-2 and identification of risk factors in the general population of the Netherlands during the first epidemic waveEric R A Vos, Gerco den Hartog, Rutger M Schepp, et al.
Open Forum Infectious Diseases|February 3, 2016
The Effect of Rosuvastatin on Markers of Immune Activation in Treatment-Naive Human Immunodeficiency Virus-PatientsRobyn G M Weijma, Eric R A Vos, Jaap Ten Oever, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
European Journal of Epidemiology|June 11, 2021
Estimating the asymptomatic proportion of SARS-CoV-2 infection in the general population: Analysis of nationwide serosurvey data in the NetherlandsScott A McDonald, Fuminari Miura, Eric R A Vos, et al.
Vaccine|November 29, 2021
Seroprevalence of meningococcal ACWY antibodies across the population in the Netherlands: Two consecutive surveys in 2016/17 and 2020Milou Ohm, Mirjam J Knol, Eric R A Vos, et al.
Nature Communications|February 20, 2026
Antibody waning and Bordetella pertussis resurgence after the COVID-19 pandemic in the NetherlandsChannah M Gaasbeek, Eric R A Vos, Annika M van Roon, et al.
Scientific Reports|March 30, 2023
Dynamics of non-household contacts during the COVID-19 pandemic in 2020 and 2021 in the NetherlandsJantien A Backer, Laurens Bogaardt, Philippe Beutels, et al.
Plos One|March 18, 2024
Health-related quality of life during the COVID-19 pandemic: The impact of restrictive measures using data from two Dutch population-based cohort studiesCheyenne C E van Hagen, Anne J Huiberts, Elizabeth N Mutubuki, et al.
Influenza and Other Respiratory Viruses|June 5, 2024
SARS-CoV-2 Seroprevalence Trends in the Netherlands in the Variant of Concern Era: Input for Future ResponseEric R A Vos, Cheyenne C E van Hagen, Denise Wong, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 27, 2021
Associations Between Measures of Social Distancing and Severe Acute Respiratory Syndrome Coronavirus 2 Seropositivity: A Nationwide Population-based Study in the NetherlandsEric R A Vos, Michiel van Boven, Gerco den Hartog, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|August 18, 2021
Circulation of Bordetella pertussis in the Caribbean Netherlands: a population-based seroepidemiological studyMaarten M Immink, Eric R A Vos, Alcira V A Janga-Jansen, et al.
Journal of Epidemiology and Community Health|November 29, 2020
Nationwide seroprevalence of SARS-CoV-2 and identification of risk factors in the general population of the Netherlands during the first epidemic waveEric R A Vos, Gerco den Hartog, Rutger M Schepp, et al.
Open Forum Infectious Diseases|February 3, 2016
The Effect of Rosuvastatin on Markers of Immune Activation in Treatment-Naive Human Immunodeficiency Virus-PatientsRobyn G M Weijma, Eric R A Vos, Jaap Ten Oever, et al.
Pageof 3